Key Kyowa Kirin, Dainippon Sumitomo drugs opened up to generics in Japan
This article was originally published in Scrip
Executive Summary
The latest reimbursement price listing of generic drugs in Japan includes nine active ingredients opened up to such competition for the first time, including Kyowa Hakko Kirin's and Dainippon Sumitomo Pharma's (DSP) number two products and others from AstraZeneca and Astellas.